Identification of genes with specific expression in pancreatic cancer by cDNA representational difference analysis

Genes Chromosomes and Cancer

Volumn 19, Issue 2, 1997, Pages 97-103

  Gress, Thomas M ^a   Wallrapp, Christine ^a   Frohme, Marcus ^c   Müller Pillasch, Friederike ^a   Lacher, Ulrike ^a   Friess, Helmut ^b   Büchler, Markus ^b   Adler, Guido ^a   Hoheisel, Jörg D ^c  

^a UNIVERSITY OF ULM   (Germany)

^b UNIVERSITY OF BERN   (Switzerland)

^c Div of Molec Genome Analysis 0842   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA;

ARTICLE; CANCER GENETICS; DNA DETERMINATION; GENE EXPRESSION; GENE SEQUENCE; HUMAN; HUMAN TISSUE; PANCREAS CANCER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANNEXIN A3; BASE SEQUENCE; DNA, COMPLEMENTARY; DNA, NEOPLASM; FIBRONECTINS; GENE EXPRESSION; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; KERATINS; MOLECULAR SEQUENCE DATA; PANCREATIC NEOPLASMS; PANCREATITIS; POLYMERASE CHAIN REACTION;

EID: 0030997924     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2264(199706)19:2<97::AID-GCC5>3.0.CO;2-V     Document Type: Article

References (24)

1. Altschul SF, Gish W, Miller W, Myers EW, Lipman D (1990) Basc local alignment research tool. J Mol Biol 215:4402.
2. Barton CM, Staddon SL, Hughes CM, Hall PA, O'Sullivan C, Klöppel G. Neoptolemos J. Williamson RGN, Lane DP, Lemoine NR (1991) Abnormalities of the p53 tumour suppressor gene in human pancreatic cancer, Br J Cancer 64:1076-1082.
3. Borsi L, Carnemolla B, Castellani P, Rosellini C, Vecchio D, Allemani G, Chang SE, Taylor-Papadimitriou J. Pnade H, Zardi L (1987) Monoclonal antibodies in the analysis of fibronectin isoforms generated by alternative splieng of mRNA precursors in normal and transformed human cells, J Cell Biol 104:595-600.
4. Borsi L, Balza E, Allemani G, Zardi L. (1992) Differential expression of the fibronectin isoform containing the ED-B oncofetal domain in normal human fibroblast cell lines originating from different tissues. Exp Cell Res 199:98-105.
5. Carnemolla B, Balza E, Siri A, Zardi L, Nicotta MR, Bigotti A, Natali PG(1989) A tumor-associated fibronectin isoform generated by alternative splicing of messenger RNA precursor. J Cell Biol 108:1139-1148.
6. Casey G, Yamanaka Y, Friess H, Kobrin MS, Lopez ME, Bücher M, Beger HG, Kore M (1993) p53 mutations are common in pancreatic cancer and are absent in chronic pancteatitis. Cancer Lett 69:151-160.
7. Castellani P, Siri A, Rosellini C, Infusini E, Borsi L, Zardi L (1986) Transformed human cells release different fibronectin variants than do normal cells. J Cell Biol 103:1671-1677.
8. Clemmons DR, Jones JI, Busby WH, Wright G (1993) Role of insulin-like growth factor binding proteins in modifying IGF actions. Ann NY Acad Sci USA 692:10-21.
9. Gress TM, Hoheisel JD, Lennon GG, Zehetner G, Lehrach H (1992) Hybridisation fingerprinting of high density cDNA-library arrays with cDNA pools derived whole tissues. Mammal Genome 3:609-619.
10. Gutman A, Kornblihtt AR (1997) Identification of a third region of cell-specific alternative splicing in human fibronectin mRNA. Proc Natl Acad Sci USA 84:7179-7182.
11. Hubank M, Scharz DG (1994) Identifying differences in mRNA expression by representational difference analysis of cDNA. Nucleic Acids Res 22:5640-5648.
12. Klöppel G (1993) Pathology of nonendncrine pancreatic tumours. In Go VLW, DiMagno EP, Gardner JD, Lebenal E, Rebr HA, Seheele GA (eds): The Pancreas: Biology, Pathobilogy and Disease, 2nd ed. New York: Raven Press, pp871-897.
13. Liang P, Pardee B (1992) Differential display of eukaryoic messenger RNA by means of the polymerase chain reaction. Science 257:967-971.
14. Lisitsyn N, Lisitsyn N, Wigler M (1993) Cloning the differences between two complex genomes. Science 259:946-951.
15. Lisitsyn NA, Lisitsina NM, Dalbagni G, Bakker P, Sanchez CA Gnarra J, Linhan WM, Reid BJ, Wigler MH (1995) Comprative genomic analysis of tumours: Detection of DNA losses and amplification. Proc Natl Acad Sci USA 92:151-155.
16. Murr MM, Starr MG, Oishi AJ, van Heerden JA (1994) Pancreatic cancer, Cancer J Clin 44:304-318.
17. Myers MH, Gloeckler-Riess LA (1989) Can patients survival rates: SEER programme for 10 years of follow-up. Cancer J Clin 39:21-32.
18. Osborn M, Weber K (1983) Biology of disease. Tumor diagnosis by intermediate filament typing: a novel tool for surgical pathology. Lab Invest 48:372-394.
19. Sarkar A, Yng P, Fan YH, Mu ZM, Hauptmann R, Adolf GR, Stass SA, Chang KS (1994) Regulation of the expression of annexin V in acute promyeloeytic leukaemia Blood 84:279-286.
20. Tawagari Y, Oikanw S, Matsuoka Y, Kosaki G, Nakzato H (1988) Primary structure of nonspecific crossreacting antigen (NCA), a member of the carcinoembryonic antigen (CEA) gene family, deduced from cDNA sequences. Biochem Biophys Res Commun 150:89-96.
21. Vilá MR, Balaguè C, Real XF (1994) Cytokeratins and mucins as molecular markers of cell differentiation and neoplastic transformation in the exocrine pancreas. Zentralbl Pathol 140:225-235.
22. Vishwanatha JK, Chiang Y, Kumble KD, Hollingworth MA, pour MA (1993) Enhanced expression of annexin II in human pancreatic caricinoma cells and primary pancreatic cancer. Carcinogenesisi 14:2575-2579.
23. Yamada K, Akiyama SK, Hasegawa T, Hasegawa E, Humphries MJ, Kennedy DW, Nagata K, Urshihar H, Olden K, Chen WT (1985) Recent advances on research of fibronectin a other cell attachment proteins. J Cell Biochem 28:78-98.
24. Ylätupa S, Haglung C, Mertaniemie P. Vahtent E, Partanen P (1995) Cellular fibronectin in serum and plasma: A potential new tumor marker. Br J Cancer 71:578-582.